{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:18:11Z","timestamp":1787897891301,"version":"build-2784847793"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Immune-mediated necrotizing myopathies (IMNMs) are a group of rare acquired myopathies. We describe two pediatric cases presenting with early-onset proximal and axial muscle weakness, rhabdomyolysis, and progressive evolution mimicking limb-girdle muscular dystrophy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective case series is based on a review of the medical records of two pediatric IMNM patients with symptom onset at 2 (P1) and 16 (P2) years of age and diagnoses at 5 and 17\u2005years, respectively. Both patients underwent clinical assessment, muscle biopsy, whole-body muscle MRI, a testing for myositis-specific and myositis-associated autoantibodies, whole-exome sequencing, and\n                      <jats:italic>in silico<\/jats:italic>\n                      analysis following informed parental consent. These data were collected and analyzed retrospectively. The manuscript was prepared in accordance with the CARE reporting guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both patients presented with an early onset of severe muscle weakness, compatible with the clinical suspicion of limb-girdle muscular dystrophy. P1\u2019s serological screening was positive for anti-signal recognition particle antibodies, and muscle biopsy revealed a myopathological pattern compatible with IMNM. Treatment with corticosteroids, intravenous immunoglobulin (IVIG), and rituximab resulted in partial amelioration of muscle strength. P2\u2019s screening for myositis autoantibodies was negative. Muscle biopsy showed a dystrophic pattern with the absence of dysferlin. Whole-exome sequencing did not identify any compatible variants explaining the muscle phenotype in both patients. P2 was treated with corticosteroids, IVIG, and rituximab, resulting in normalization of muscle weakness and creatine kinase (CK) levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IMNM should be considered in pediatric patients with clinical and paraclinical suspicion of inherited muscular dystrophy. Serological testing is crucial for identifying seropositive cases. In the presence of seronegative or more complex cases, a global paraclinical and genetic analysis is essential to avoid misdiagnosis and initiate long-term immunosuppressive therapy, including corticosteroids, IVIG, and rituximab.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1906576","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:35:42Z","timestamp":1787895342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Pediatric immune-mediated necrotizing myopathies mimicking inherited muscle disorders: clinical, paraclinical, and genetic insights from two cases"],"prefix":"10.3389","volume":"14","author":[{"given":"Gianmarco","family":"Severa","sequence":"first","affiliation":[{"name":"University Paris Est Cr\u00e9teil, Inserm, U955, IMRB","place":["Cr\u00e9teil, France"]},{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Camila","family":"Cortes-Rojas","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]},{"name":"Child Neurology Department, Hospital Militar Central","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gomez-Garcia de la Banda","sequence":"additional","affiliation":[{"name":"Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, AP-HP, GHU Universit\u00e9 Paris-Saclay","place":["Garches, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Belmondo","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Immuno-H\u00e9matologie, GHU AP-HP, H\u00f4pitaux Universitaires Henri-Mondor, APHP","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Benezit","sequence":"additional","affiliation":[{"name":"Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, AP-HP, GHU Universit\u00e9 Paris-Saclay","place":["Garches, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Leturcq","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine G\u00e9nomique des Maladies de Syst\u00e8me et d'Organe, F\u00e9d\u00e9ration de G\u00e9n\u00e9tique et de M\u00e9decine G\u00e9nomique, APHP, Centre\u2014Universit\u00e9 Paris Cit\u00e9, H\u00f4pital Cochin","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Verebi","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine G\u00e9nomique des Maladies de Syst\u00e8me et d'Organe, F\u00e9d\u00e9ration de G\u00e9n\u00e9tique et de M\u00e9decine G\u00e9nomique, APHP, Centre\u2014Universit\u00e9 Paris Cit\u00e9, H\u00f4pital Cochin","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Periou","sequence":"additional","affiliation":[{"name":"University Paris Est Cr\u00e9teil, Inserm, U955, IMRB","place":["Cr\u00e9teil, France"]},{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona","place":["Barcelona, Spain"]},{"name":"Biomedical Research Institute Sant Pau (IIB Sant Pau)","place":["Barcelona, Spain"]},{"name":"Biomedical Network Research Centre on Rare Diseases (CIBERER)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Cassandrini","sequence":"additional","affiliation":[{"name":"Immunology Unit, University Hospital, Azienda Ospedaliera Universitaria Integrata","place":["Verona, Italy"]},{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Gendre","sequence":"additional","affiliation":[{"name":"Neurology Department, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hue","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Immuno-H\u00e9matologie, GHU AP-HP, H\u00f4pitaux Universitaires Henri-Mondor, APHP","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Gitiaux","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, Filnemus, EuroNMD, Assistance Publique-H\u00f4pitaux de Paris (APHP) Necker Enfants Malades Hospital","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Toubal","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU IBN ROCHD, Facult\u00e9 de M\u00e9decine, Universit\u00e9 BADJI MOKHTAR","place":["Annaba, Algeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Nouioua","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cherchell EHS","place":["Tipaza, Algeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Boucher","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Pediatrics, ANNABA University Hospital, Badji Mokhtar University","place":["Annaba, Algeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[{"name":"Department for Immunology, Hematology and Pediatric Rheumatology, Necker Hospital, APHP, Institut IMAGINE","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois J\u00e9r\u00f4me","family":"Authier","sequence":"additional","affiliation":[{"name":"University Paris Est Cr\u00e9teil, Inserm, U955, IMRB","place":["Cr\u00e9teil, France"]},{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Yves","family":"Carlier","sequence":"additional","affiliation":[{"name":"APHP, Universit\u00e9 UVSQ-Paris Saclay, H\u00f4pital Raymond Poincar\u00e9, Service de Radiologie","place":["Garches, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Quijano-Roy","sequence":"additional","affiliation":[{"name":"Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, AP-HP, GHU Universit\u00e9 Paris-Saclay","place":["Garches, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Malfatti","sequence":"additional","affiliation":[{"name":"University Paris Est Cr\u00e9teil, Inserm, U955, IMRB","place":["Cr\u00e9teil, France"]},{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"103286","DOI":"10.1016\/j.jaut.2024.103286","article-title":"Immune-mediated necrotizing myopathy: a comprehensive review of the pathogenesis, clinical features, and treatments","volume":"148","author":"Li","year":"2024","journal-title":"J Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1123380","DOI":"10.3389\/fneur.2023.1123380","article-title":"Pediatric immune-mediated necrotizing myopathy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"123414","DOI":"10.1016\/j.jns.2025.123414","article-title":"Cardiac involvement and anti-striational antibodies in immune-mediated necrotizing myopathy","volume":"470","author":"Sumi","year":"2025","journal-title":"J Neurol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.autrev.2021.102993","article-title":"Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge","volume":"21","author":"Merlonghi","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1002\/mus.26375","article-title":"A child with antibody-negative immune-mediated necrotizing myopathy","volume":"59","author":"Karakas","year":"2019","journal-title":"Muscle Nerve"},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","article-title":"Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies","volume":"56","author":"Liang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2340\/16501977-0235","article-title":"Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy","volume":"40","author":"Paternostro-Sluga","year":"2008","journal-title":"J Rehabil Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"29769","DOI":"10.1074\/jbc.M301539200","article-title":"Sox8 is a specific marker for muscle satellite cells and inhibits myogenesis","volume":"278","author":"Schmidt","year":"2003","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17562864251317961","DOI":"10.1177\/17562864251317961","article-title":"CACNA1S-associated triadopathy presenting with myalgia, muscle weakness, and asymptomatic hyperCKemia","volume":"18","author":"Luo","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41927-020-00128-5","article-title":"Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report","volume":"4","author":"Thomas","year":"2020","journal-title":"BMC Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"670784","DOI":"10.3389\/fneur.2021.670784","article-title":"The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China","volume":"12","author":"Ma","year":"2021","journal-title":"Front Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2050313X241298862","DOI":"10.1177\/2050313X241298862","article-title":"Atypical presentation of anti-small ubiquitin-like modifier 1 and melanoma differentiation-associated gene 5 antibody positive dermatomyositis presenting with significant inflammatory myopathy on biopsy and normal creatine kinase levels: a case report","volume":"12","author":"Sama","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12920-022-01284-y","article-title":"Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review","volume":"15","author":"Contreras-Cubas","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.3390\/jcm12186011","article-title":"Portrait of dysferlinopathy: diagnosis and development of therapy","volume":"12","author":"Bouchard","year":"2023","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.3390\/ijms25115572","article-title":"Limb girdle muscular dystrophy type 2B (LGMD2B): diagnosis and therapeutic possibilities","volume":"25","author":"Poudel","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nmd.2021.01.009","article-title":"Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease","volume":"31","author":"Moore","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0960-8966(00)00143-7","article-title":"Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)","volume":"10","author":"Anderson","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.3390\/jcm11216566","article-title":"The clinicopathological distinction between immune-mediated necrotizing myopathy and limb-girdle muscular dystrophy R2: key points to prevent misdiagnosis","volume":"11","author":"Yang","year":"2022","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2025.03.002","article-title":"Pediatric immune-mediated necrotizing myopathy: a single-center retrospective cohort study","volume":"167","author":"Wang","year":"2025","journal-title":"Pediatr Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.nmd.2023.02.007","article-title":"Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern","volume":"33","author":"Llans\u00f3","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mus.28114","article-title":"Management of immune-mediated necrotizing myopathy","volume":"70","author":"Suh","year":"2024","journal-title":"Muscle Nerve"},{"key":"B26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41379-018-0164-x","article-title":"A pattern-based approach to the interpretation of skeletal muscle biopsies","volume":"32","author":"Cai","year":"2019","journal-title":"Mod Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s40674-023-00210-2","article-title":"Treatment of immune-mediated necrotizing myopathy","volume":"9","author":"Ogbonnaya-Whittlesey","year":"2023","journal-title":"Curr Treatm Opt Rheumatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1906576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:35:44Z","timestamp":1787895344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1906576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":27,"alternative-id":["10.3389\/fped.2026.1906576"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1906576","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1906576"}}